Navigation Links
Paliperidone in Medical News

Study Suggests Treatment with Paliperidone ER Significantly Improves Symptoms of Schizoaffective Disorder

SAN DIEGO, April 1 /PRNewswire/ -- Patients with schizoaffective disorder who received paliperidone extended release tablets (paliperidone ER) for six weeks showed significant improvement in a broad range of schizoaffective symptoms, according to a new study presented today at the 12th Internation...

Johnson & Johnson Pharmaceutical Research & Development Submits New Drug Application for Paliperidone Palmitate

TITUSVILLE, N.J., Oct. 29 /PRNewswire/ -- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) for paliperidone palmitate, an investigational, once-monthly atypical antipsy...

FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia

...INVEGA SUSTENNA is available in milligrams (mg) of paliperidone palmitate in dose strengths of 39 mg, 78 mg, 117 m...equivalents (mg eq.) to paliperidone. Each dose of paliperidone palmitate is equivalent to a specific dose of paliperidone (39 mg, 78 mg, 117 mg, 156 mg and 234 mg of...

INVEGA(R) Approved as the First and Only Treatment for Schizoaffective Disorder

... antipsychotic medication, was first approved in the U.S. in December 2006. Janssen(R), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc, markets paliperidone ER as INVEGA(R). It is approved for the acute and maintenance treatment of schizophrenia in the U.S. and for the treatment of schizophrenia in the E.U...

Effective new treatment for schizophrenia

... placebo-controlled trial. The authors studied paliperidone extended-release (ER) tablets, an investigational ...four treatments for 6 weeks: 6 mg or 12 mg/day of paliperidone ER, 10 mg/day of olanzapine (the active comparator...s: This double-blind study found that two doses of paliperidone extended release tablets were more effective than ...

INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia

...these are divided into both positive and negative symptoms. References (1) Kramer M, Simpson G, Kushner S et al., Long-term safety/tolerability of paliperidone extended-release tablets: 52-week, open-label, extension phase of a schizophrenia symptom recurrence prevention study, December 2007 ...

INVEGA Receives Marketing Authorization In EU For Treatment Of Schizophrenia

...ase tablets), an atypical antipsychotic medication for the treatment of schizophrenia. This once-daily medication is specifically designed to deliver paliperidone - the active ingredient in INVEGA - through the innovative osmotic delivery system (OROS(R)). In clinical trials, INVEGA demonstrated significant effi...

INVEGA(TM) Gets Marketing Authority from EU to Treat Schizophrenia

...ase tablets), an atypical antipsychotic medication for the treatment of schizophrenia. This once-daily medication is specifically designed to deliver paliperidone - the active ingredient in INVEGA - through the innovative osmotic delivery system (OROS(R)). In clinical trials, INVEGA demonstrated signific...
Paliperidone in Medical Technology

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)

TITUSVILLE, N.J., Feb. 6 /PRNewswire/ -- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) today announced that the company has submitted multiple applications to the U.S. Food and Drug Administration (FDA) which, if approved, would broaden treatment options for...

Study Suggests Treatment with Paliperidone ER Significantly Improves Symptoms of Schizoaffective Disorder

First Clinical Study of Paliperidone ER in this Under-Studied Condition SAN DIEGO, Nov. 1 /PRNewswire/ -- Patients with schizoaffective disorder receiving paliperidone extended release tablets (paliperidone ER) for six weeks showed a significant improvement in their symptoms, according to a ne...

Blood Levels of Paliperidone Extended-Release Tablets are Not Increased by Common Antidepressant

Study shows paroxetine produced no significant drug interaction with paliperidone ER SAN DIEGO, May 22, 2007 /PRNewswire/ -- After administration of paliperidone extended-release (ER) tablets, blood levels of the drug were not affected when given with a common antidepressant, according to new data...

Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia

... SUSTENNA(TM) is available in milligrams (mg) of paliperidone palmitate in dose strengths of 39 mg, 78 mg, 117 m...equivalents (mg eq.) to paliperidone. Each dose of paliperidone palmitate is equivalent to a specific dose of paliperidone (39 mg, 78 mg, 117 mg, 156 mg and 234 mg of...
Paliperidone in Biological Technology

Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia

Results of Two Trials Identify Potential Initiation Dosing Regimen TITUSVILLE, N.J., Dec. 10 /PRNewswire/ -- Paliperidone palmitate, an investigational long-acting therapy (LAT) demonstrated statistically significant symptom control compared with placebo according to the results of a 13-w...

Treatment with Paliperidone ER May Be Associated with Significantly Reduced Use of Mental Health Resources

Separate Analysis Suggests Paliperidone ER May Impact Employment Status WASHINGTON, May 7 /PRNewswire-FirstCall/ -- Patients receiving paliperidone extended-release tablets (paliperidone ER) spent significantly fewer days in the hospital, had significantly fewer emergency room and psychiatric-...

Topline Findings from Comparative Analysis of INVEGA(TM) and Quetiapine in Schizophrenia to be Postered at the 20th Annual U.S. Psychiatric and Mental Health Congress

... U.S. Psychiatric and Mental Health Congress, which takes place October 11-14, 2007 in Kissimmee, FL. The poster, entitled "A Comparative Analysis of paliperidone ER and Quetiapine in Patients With a Recent, Acute Exacerbation of Schizophrenia" will be on display on Saturday, Oct. 13 from 2:15 p.m. to 5:15 p.m. ...
Other Tags
(Date:9/17/2014)... 2014 North Central Surgical Center is ... awards for their top-notch services. The hospital was the ... and GYN surgery. , Hospital-wide, North Central was the ... have received this award for two years in a ... percent in the nation for Patient Safety in 2014 ...
(Date:9/17/2014)... WEDNESDAY, Sept. 17, 2014 (HealthDay News) -- A blood ... could provide doctors with a better assessment of the ... If used routinely, this blood test could ... working and actually begins promoting tumor growth, the researchers ... given to patients with advanced prostate cancer and often ...
(Date:9/17/2014)... York, New York (PRWEB) September 17, 2014 ... filings involving the Conserve line of metal-on-metal hip ... now underway in U.S. District Court, Northern District ... an updated Case List issued by the U.S. ... 2014, at least 397 product liability claims have ...
(Date:9/17/2014)... September 17, 2014 Why are Asian Americans at ... Americans, and prone to develop the disease at lower ... in the transition from traditional high-fiber, low-fat Asian diets ... for those of Asian heritage, says George King, M.D., ... Diabetes Center and the senior author of the study. ...
(Date:9/17/2014)... The in vitro diagnostics (IVD) marketplace ... focusing on molecular diagnostics for conditions such as infectious ... The IVD market value is projected to be worth ... The major drivers of the market’s growth include the ... evidenced by the explosion for raid and minimally-invasive diagnostic ...
Breaking Medicine News(10 mins):Health News:North Central Surgical Center Receives Several Accolades 2Health News:DNA Blood Test Might Identify Status of Prostate Cancer 2Health News:Wright Hip Lawsuit News: Nearly 400 Filings Reported in Federal Wright Conserve Hip Replacement Litigation, Bernstein Liebhard LLP Reports 2Health News:Wright Hip Lawsuit News: Nearly 400 Filings Reported in Federal Wright Conserve Hip Replacement Litigation, Bernstein Liebhard LLP Reports 3Health News:In Joslin trial, Asian Americans lower insulin resistance on traditional diet 2Health News:In Joslin trial, Asian Americans lower insulin resistance on traditional diet 3Health News:World In Vitro Diagnostics Market Analysed by VPG in In-demand Research Report Available at MarketPublishers.com 2Health News:World In Vitro Diagnostics Market Analysed by VPG in In-demand Research Report Available at MarketPublishers.com 3
(Date:9/17/2014)... State,s Institute for the Arts and Humanities has received ... for a two-year project, "The Boundaries of the Human ... project will support a wide-ranging series of events aimed ... humanities. One involves artists and researchers who are exploring ... the idea of humanism, and the other involves the ...
(Date:9/17/2014)... has developed, very cleverly, some lessons on how to ... said Joseph Shaw, director of the Optical Technology Center ... structures at the nanoscale, we,ll discover them." , Some ... August during a conference called "The Nature of Light: ... of the University of Arizona College of Optical Sciences. ...
(Date:9/17/2014)... A team of Spanish researchers have obtained the first ... a sixteenth century pig found at the site of ... that this ancient pig is closely related to today,s ... pigs were crossed with modern Iberian pigs. , The ... on evolutionary aspects of pig species, and particularly on ...
Breaking Biology News(10 mins):Mellon Foundation awards grant for major project in the humanities and sciences 2Nature's designs inspire research into new light-based technologies 2Nature's designs inspire research into new light-based technologies 3Iberian pig genome remains unchanged after 5 centuries 2
Other Contents